Exploring and identifying the imaging biomarkers for predicting anti-VEGF treatment response in polypoidal choroidal vasculopathy: a prospective multicenter study.
Wenfei ZhangXingwang GuBing LiShulin LiuJingyuan YangYue-Lin WangShiyu ChengLin LvZhiqing LiLinna LuJinghong ZhangQi ZengZefeng XiaoGuangfeng LiuCai XinTianyu ZhangYingdan SuMinyu ChenChengshu WangYonkang CunXinyu ZhaoYou-Xin ChenPublished in: Annals of medicine (2024)
Thinner SFCT and lower CVI can serve as imaging biomarkers for predicting good treatment response to anti-VEGF monotherapy in PCV patients. The nomogram based on these biomarkers exhibited satisfactory performances.
Keyphrases
- high resolution
- end stage renal disease
- vascular endothelial growth factor
- endothelial cells
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- combination therapy
- randomized controlled trial
- optical coherence tomography
- squamous cell carcinoma
- lymph node metastasis
- clinical trial
- patient reported outcomes
- mass spectrometry